Tag: pharmacare

Posted on November 13, 2016

BIG PHARMA AND HIGH COST BIOLOGICS: Raymond Rupert MD, MBA.

Sovaldi is a new biologic produced by Gilead Sciences to treat and cure hepatitis C. The cost for 2 months of treatment with Sovaldi in Egypt is $800. In Canada, Sovaldi costs $55,000. Gilead has a solid hold on the market for hepatitis C with 27 patents for Sovaldi. When analyzed, the patents are base […] Read More

Posted on October 7, 2015

Mark Rovere: With Pharmacare, the cure is worse than the disease; The NO Side of the argument.

National Post | July 6, 2011 7:30 AM ET By Mark Rovere There has been much discussion in the past 10 years about whether Canada needs a national Pharmacare plan. Unfortunately, the plan is driven by ideology as opposed to common sense. While reform of provincial drug plans is necessary, a national government plan will […] Read More

Posted on October 6, 2015

NATIONAL PHARMACARE FOR CANADA- THE YES SIDE OF THE DEBATE- CMAJ March 2015

Steven G. Morgan PhD, Michael Law PhD, Jamie R. Daw BHSc MSc, Liza Abraham BSc, Danielle Martin MD MPubPol Competing interests: Michael Law reports receiving personal fees from Health Canada outside of the submitted work. Danielle Martin is a volunteer member of the board of Canadian Doctors for Medicare. Correspondence to: Steven Morgan, steve.morgan@ubc.ca Background: […] Read More